Search results
Results From The WOW.Com Content Network
Price Action: ILMN stock is down 0.12% at $143.70 at the last check on Monday. Also Read: What’s Going On With Moderna Stock On Monday? ... ILLUMINA (ILMN): Free Stock Analysis Report.
In the latest trading session, Illumina (ILMN) closed at $199.32, marking a -1.64% move from the previous day.
Illumina (ILMN) delivered earnings and revenue surprises of 17.24% and 1.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
For premium support please call: 800-290-4726 more ways to reach us
Illumina, Inc. ( NASDAQ:ILMN ) shareholders should be happy to see the share price up 19% in the last month. But that's...
In September 2020, Illumina announced a proposed cash and stock deal to acquire Grail for $8 billion. [28] [29] In November 2018, Illumina proposed the acquisition of Pacific Biosciences for $8.00 per share or around $1.2 billion in total. [30] [31] In December 2019, the Federal Trade Commission (FTC) sued to block the acquisition. [32]
Shareholders will receive one common share of Grail for every six shares of Illumina, which will retain a 14.5% stake in the unit after the spinoff on June 24. Shares of Illumina were up 4% in ...